TrialThe New England journal of medicine2023
Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma.
Michiel S van der Heijden et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
299 papers cite itlatest 60 shown
this paperpooled ittrialcites it